ライフサイエンスコーパス: eligible for inclusion if they

1 Studies were eligible for inclusion if they assessed the potential di

2 Children were eligible for inclusion if they attended one of the 12 se

3 Studies were eligible for inclusion if they compared surgical interve

4 th a diagnosis of HCM from 2018 onwards were eligible for inclusion if they had >=1 mavacamten prescr

5 a clinical diagnosis of phenylketonuria were eligible for inclusion if they had a blood Phe concentra

6 Women were eligible for inclusion if they had a gestational age of

7 Patients were eligible for inclusion if they had acute ischaemic strok

8 Participants were eligible for inclusion if they had available plasma p-ta

9 Schools were eligible for inclusion if they had both male and female

10 Patients were eligible for inclusion if they had cancer and were takin

11 Patients were eligible for inclusion if they had chronic HCV infection

12 Participants were eligible for inclusion if they had culture-confirmed B p

13 Patients (>=18 years old) were eligible for inclusion if they had histologically docume

14 EUCAN-Connect projects were invited and were eligible for inclusion if they had information on GA and

15 Patients were eligible for inclusion if they had newly diagnosed multi

16 ls of blood pressure lowering treatment were eligible for inclusion if they included a minimum of 100

17 Trials were eligible for inclusion if they included any of the appro

18 The subdistricts were eligible for inclusion if they included participants tha

19 t ventricular ejection fraction (<=35%) were eligible for inclusion if they met guideline-based crite

20 Women were eligible for inclusion if they permanently lived in clus

21 Women were eligible for inclusion if they permanently lived in the

22 Cohorts were eligible for inclusion if they prospectively recruited a

23 Cohorts were eligible for inclusion if they prospectively recruited c

24 Studies were eligible for inclusion if they provided an estimate for

25 Trials were eligible for inclusion if they randomised women consider

26 Studies were eligible for inclusion if they reported a measure of the

27 Studies were eligible for inclusion if they reported an assessment of

28 Studies were eligible for inclusion if they reported an effect size o

29 Studies were eligible for inclusion if they reported laboratory-confi

30 Studies were eligible for inclusion if they reported on the importanc

31 of randomised controlled trials (RCTs) were eligible for inclusion if they reported venous thromboem

32 ng disease aged between 18 and 80 years were eligible for inclusion if they required histopathologica

33 Studies were eligible for inclusion if they used population-based reg

34 Studies were eligible for inclusion if they were (1) double-blind ran

35 Patients were eligible for inclusion if they were 18 years or older an

36 Patients were eligible for inclusion if they were adults admitted to g

37 Incarcerated individuals were eligible for inclusion if they were aged 18 years or old

38 Patients were eligible for inclusion if they were aged 18 years or old

39 een Aug 16, 2010, and Dec 13, 2010, and were eligible for inclusion if they were aged 18-70 years, ha

40 Patients were eligible for inclusion if they were aged 2 years or olde

41 Participants were eligible for inclusion if they were aged 25-64 years, ha

42 nts with progressive multiple sclerosis were eligible for inclusion if they were aged 25-65 years and

43 Patients were eligible for inclusion if they were aged 30 years or old

44 Infants were eligible for inclusion if they were aged between 4 days

45 Patients were eligible for inclusion if they were ages 18 to 40 years,

46 Participants were eligible for inclusion if they were currently pregnant,

47 Children were eligible for inclusion if they were healthy, were born a

48 dological quality scoring system were deemed eligible for inclusion if they were laboratory studies u

49 ous, not pregnant, and not sex workers, were eligible for inclusion if they were literate, had no kno

50 Adolescents were eligible for inclusion if they were living with HIV, reg

51 Patients were eligible for inclusion if they were more than 16 years o

52 Patients were eligible for inclusion if they were older than 18 years,

53 Studies were eligible for inclusion if they were phase 3 randomized c

54 Studies were eligible for inclusion if they were published in the pee

55 Individuals were eligible for inclusion if they were seropositive for HCV

56 Women were eligible for inclusion if they were undergoing invasive